세계의 첨단 치료 의약품 위탁개발생산(CDMO) 시장 보고서(2025년)

An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that aids in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to offer the expertise, infrastructure, and resources necessary for the development and production of these advanced therapies.

The main types of products handled by advanced therapy medicinal product CDMOs include gene therapy, cell therapy, and tissue-engineered products. Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This process can utilize viral or non-viral vectors to deliver therapeutic genes to target cells across various phases, such as phase I, phase II, phase III, and phase IV clinical trials. These therapies address a range of indications, including oncology, cardiology, central nervous system and musculoskeletal conditions, infectious diseases, dermatology, endocrine and metabolic disorders, genetic diseases, immunology and inflammation, ophthalmology, and hematology.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides advanced therapy medicinal products contract development and manufacturing organization (CDMO) market statistics, including the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with advanced therapy medicinal products contract development and manufacturing organization (CDMO) market share, detailed advanced therapy medicinal products contract development and manufacturing organization (CDMO) market segments, market trends, and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry. These advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size has grown rapidly in recent years. It will grow from $5.31 billion in 2024 to $6.2 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to the increasing number of ATMP clinical trials, rising awareness and belief among researchers regarding the benefits of advanced therapy, the presence of several ATMP CDMOs, increasing efforts to develop novel therapies for various diseases, and supportive government initiatives.

The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to $11.12 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to the high investment of CDMOs, a growing number of emerging players in the cell and gene therapy (CGT) sector, increasing grants and investments for the development of cell and gene therapies, increasing pharmaceutical R&D spending, increasing number of clinical trials for ATMPs. Major trends in the forecast period include advancements in AAV biomanufacturing facilities, expansion of cell and gene therapy manufacturing, technological advancements in cell and gene therapy, increasing need for access to advanced platforms and technologies, and incorporating advanced technologies such as CRISPR and next-generation sequencing for heightened accuracy.

The forecast of 15.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of viral vector production and cell therapy manufacturing equipment sourced from Switzerland and South Korea, thereby delaying breakthrough gene therapies and elevating biopharmaceutical development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the advanced therapy medicinal products CDMO market is anticipated to be propelled by the increasing number of clinical trials. Clinical trials, which are research studies conducted in humans to assess the safety and efficacy of medical interventions such as drugs, treatments, devices, or preventive measures, are on the rise to meet the growing demand for innovative treatments and to tackle the increasing global disease burden. The utilization of advanced therapy medicinal products leads to a heightened demand for CDMO manufacturing services, which leverage specialized expertise and infrastructure. Clinical trial data assists in optimizing manufacturing processes, ensuring scalability, and maintaining quality to meet larger clinical and commercial demands. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported a marginal increase of 4.3% in the overall number of industry clinical trials initiated in the UK per year, rising from 394 in 2021 to 411 in 2022. Thus, the escalating number of clinical trials is propelling the growth of the advanced therapy medicinal products CDMO market.

Major players in the advanced therapy medicinal products CDMO market are focusing on developing advanced cell therapy manufacturing services to address critical issues in cell therapy manufacturing and accelerate the development activities of their partners. These cell therapy manufacturing services, offered by contract development and manufacturing organizations, encompass services ranging from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company specializing in cell solutions, introduced PluriCDMO, a new business division offering cell therapy manufacturing services. PluriCDMO utilizes a patented bioreactor system enabling 3D cell multiplication, facilitating the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aims to deliver high-quality medicines to patients while ensuring batch-to-batch consistency in a scalable and cost-effective manner within good manufacturing practice settings.

In February 2022, Recipharm AB, a Sweden-based contract development and manufacturing organization (CDMO), acquired Vibalogics for an undisclosed sum. This acquisition is intended to bolster Recipharm's presence in advanced therapy medicinal products and enable expansion into additional biologic modalities such as viral vectors. The acquisition will allow Recipharm to broaden its technologies and modalities, positioning it to better serve the growing demand for specialist CDMO capabilities in viral manufacturing within the rapidly expanding biopharmaceutical industry. Vibalogics is a Germany-based virotherapy CDMO specializing in manufacturing oncolytic viruses, viral vaccines, and gene therapies.

Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market includes revenues earned by entities by providing services such as process development, analytical method development, good manufacturing practice manufacturing, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products CDMO market also includes sales of bioreactors and fermenters, cryopreservation equipment, and laboratory instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced therapy medicinal products contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced therapy medicinal products contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Gene Therapy; Cell Therapy; Tissue Engineered
• 2) By Phase: Phase I; Phase II; Phase III; Phase IV
• 3) By Indication: Oncology; Cardiology; Central Nervous System And Musculoskeletal; Infectious Disease; Dermatology; Endocrine, Metabolic, Genetic; Immunology And Inflammation; Ophthalmology; Hematology
• Subsegments:
• 1) By Gene Therapy: Viral Vectors; Non-Viral Vectors; Dna Or Rna-Based Products
• 2) By Cell Therapy: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy
• 3) By Tissue Engineered: Skin Substitutes; Cartilage And Bone Tissue; Vascular Grafts And Organs
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Resonac Corporation; Lonza Group AG; Catalent Inc.; Charles River Laboratories International Inc.; Recipharm AB; KBI Biopharma; Takara Bio Inc.; Rentschler Biopharma SE; Ajinomoto Co. Inc.; ElevateBio LLC; Fujifilm Diosynth Biotechnologies; Axplora Group GmbH; WuXi Advanced Therapies Inc.; Celonic Group; Batavia Biosciences B.V.; BioCentriq; Cytovance Biologics; Andelyn Biosciences; Genezen; AGC Biologics; ABL Manufacturing; Minaris Regenerative Medicine; Porton Advanced Solutions
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
• 5.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 6.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Cell Therapy
• Tissue Engineered
• 6.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Central Nervous System And Musculoskeletal
• Infectious Disease
• Dermatology
• Endocrine, Metabolic, Genetic
• Immunology And Inflammation
• Ophthalmology
• Hematology
• 6.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Non-Viral Vectors
• DNA Or RNA-Based Products
• 6.5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Cell Therapy
• Allogeneic Cell Therapy
• Stem Cell Therapy
• 6.6. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Substitutes
• Cartilage And Bone Tissue
• Vascular Grafts And Organs

7. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

• 7.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 8.1. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 9.1. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 9.2. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 10.1. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 11.1. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 11.2. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 12.1. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 13.1. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 14.1. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 14.2. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 15.1. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 15.2. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 16.1. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 17.1. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 18.1. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 19.1. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 20.1. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 21.1. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 21.2. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 22.1. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 23.1. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 23.2. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 24.1. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 24.2. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 25.1. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 25.2. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 26.1. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 26.2. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 27.1. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 28.1. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 28.2. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

• 29.1. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
• 29.2. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

• 30.1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
• 30.2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Resonac Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories International Inc.
• 31.2. Recipharm AB
• 31.3. KBI Biopharma
• 31.4. Takara Bio Inc.
• 31.5. Rentschler Biopharma SE
• 31.6. Ajinomoto Co. Inc.
• 31.7. ElevateBio LLC
• 31.8. Fujifilm Diosynth Biotechnologies
• 31.9. Axplora Group GmbH
• 31.10. WuXi Advanced Therapies Inc.
• 31.11. Celonic Group
• 31.12. Batavia Biosciences B.V.
• 31.13. BioCentriq
• 31.14. Cytovance Biologics
• 31.15. Andelyn Biosciences

32. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

35. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

• 35.1 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer